1 |
Christenson SA, Smith BM, Bafadhel M, et al. Chronic obstructive pulmonary disease[J]. Lancet, 2022, 399(10342): 2227-2242.
|
2 |
Ferrera MC, Labaki WW, Han MK. Advances in chronic obstructive pulmonary disease[J]. Annu Rev Med, 2021, 72: 119-134.
|
3 |
Yang IA, Jenkins CR, Salvi SS. Chronic obstructive pulmonary disease in never-smokers: risk factors, pathogenesis, and implications for prevention and treatment[J]. Lancet Respir Med, 2022, 10(5): 497-511.
|
4 |
杨 晓. AECOPD与急性心肌梗塞相关性的研究进展[J]. 四川解剖学杂志,2020, 28(03): 194-195.
|
5 |
MacLeod M, Papi A, Contoli M, et al. Chronic obstructive pulmonary disease exacerbation fundamentals: Diagnosis, treatment, prevention and disease impact[J]. Respirology, 2021, 26(6): 532-551.
|
6 |
Xu H, Zheng X, Ai J, et al. Hemoglobin, albumin, lymphocyte, and platelet (HALP) score and cancer prognosis: A systematic review and meta-analysis of 13,110 patients[J]. Int Immunopharmacol, 2023, 114: 109496.
|
7 |
Farag CM, Antar R, Akosman S, et al.What is hemoglobin, albumin,lymphocyte, platelet (HALP) score? A comprehensive literature review of HALP′s prognostic ability in different cancer types[J]. Oncotarget, 2023, 14: 153-172.
|
8 |
梁振宇,王凤燕,陈荣昌. 慢性阻塞性肺疾病诊治指南(2021年修订版)的重要更新解读及展望[J]. 国际呼吸杂志,2021, 41(19): 1457-1461.
|
9 |
Tang W, Zha ML, Zhang WQ, et al. APACHE scoring system and pressure injury risk for intensive care patients: A systematic review and meta-analysis[J]. Wound Repair Regen, 2022, 30(4): 498-508.
|
10 |
毛 俊,纪莉莎,张子蓉. 基于血红蛋白、白蛋白、淋巴细胞和血小板评分建立的列线图对非小细胞肺癌患者总生存期的预测价值[J]. 中国临床医生杂志,2023, 51(5): 545-551.
|
11 |
Long B, Rezaie SR. Evaluation and management of asthma and chronic obstructive pulmonary disease exacerbation in the emergency department[J]. Emerg Med Clin North Am, 2022, 40(3): 539-563.
|
12 |
夏婷婷,张 建. 慢性阻塞性肺疾病急性加重期(AECOPD)的中医治疗进展[J]. 新疆中医药,2022, 40(3): 110-114.
|
13 |
董素素,梅 牧,王天立,等. AECOPD患者T淋巴细胞与肺功能及炎症指标的相关性研究[J]. 数理医药学杂志,2023, 36(7): 543-548.
|
14 |
白景山,刘靖轩,张 琴,等. 常见血炎症标志物在慢性阻塞性肺疾病急性加重期中的预测价值[J]. 赣南医学院学报,2023, 43(3): 240-246.
|
15 |
杨丽青,高凌云,杨凌婧,等. 慢性阻塞性肺疾病急性加重住院病人一年内再住院危险因素分析[J]. 西南医科大学学报,2022, 45(5): 404-408.
|
16 |
姚 兰,黄毅岚,舒泸莹,等. 低分子量肝素钙联合沙丁胺醇雾化吸入及无创正压通气治疗COPD急性加重合并II型呼吸衰竭的疗效[J]. 西南医科大学学报,2022, 45(4): 332-336.
|
17 |
张 艳,王春梅. 血红蛋白和白蛋白水平与慢性阻塞性肺疾病急性加重期患者预后的相关性[J]. 中国临床研究,2020, 33(8): 1094-1096,1100.
|
18 |
张 旭,董亚琼. NUTRIC营养评分联合血红蛋白对AECOPD合并Ⅱ型呼吸衰竭的预后研究[J]. 贵州医药,2021, 45(3): 392-393.
|
19 |
周 玲,涂兴蕊,冯 隽,等. AECOPD患者血清NEUT、LY、PLT与CRP的相关性及对患者预后的诊断价值[J]. 贵州医科大学学报,2022, 47(4): 445-450.
|
20 |
MacNeil JL, Capaldi DPI, Westcott AR, et al. Pulmonary imaging phenotypes of chronic obstructive pulmonary disease using multiparametric response maps[J]. Radiology, 2020, 295(1): 227-236.
|
21 |
宋文斌. 血清hs-CRP、ALB水平对AECOPD合并Ⅱ型呼吸衰竭患者30 d内再入院的预测价值[J]. 河南医学研究,2021, 30(26): 4882-4885.
|
22 |
Libu C, Otelea MR, Arghir IA, et al. Challenges in diagnosing occupational chronic obstructive pulmonary disease[J]. Medicina (Kaunas), 2021, 57(9): 911.
|